Ajesh Thomas is a high-impact Senior Finance Leader and Strategic Advisor with over 15 years of experience driving value creation across global pharmaceutical giants and private equity-backed portfolios. With an International Executive MBA from the University of St. Gallen and a CIMA qualification, Ajesh specializes in bridging the gap between complex financial architecture and aggressive commercial scale-up. His deep roots in the Swiss life sciences ecosystem include a tenure at Novartis, where he acted as a key finance partner for R&D and manufacturing units, overseeing budgets exceeding €500m and architecting five-year strategic roadmaps. Beyond big pharma, Ajesh has been a pivotal force in early-stage SaaS ventures and private equity environments, including KKR’s Selecta AG and Swiss Mobiliar’s bexio AG. He brings specialized expertise in group-wide P&L, cash, working capital management and liquidity optimization, ensuring that high-growth ventures maintain the capital efficiency required for rapid scaling. By implementing sophisticated enterprise performance cockpits and digital finance initiatives, he transforms raw data into actionable investor intelligence. At Nimverta, he provides the financial stewardship and rigorous cash management required to navigate the complexities of biotech R&D, ensuring the company’s first-in-class peptide therapies are built upon a transparent, scalable, and exit-ready financial foundation.